: The recurrence rate of atrial fibrillation (AF) after electrical cardioversion (ECV) appears to correlate with morpho-functional changes in both the left (LA) and right atria (RA). The present study focuses on identifying predictors for AF recurrence post-ECV. : Sixty-one patients were included in the study following an elective ECV with a successful conversion to SR, and were subjected to cardiovascular assessment immediately after ECV. : At 6-month follow-up, 24 patients (39.3%) experienced AF recurrence. Patients without AF recurrence showed a lower right atrial valvular index (RAVi) (32 ± 8 vs. 40 ± 10 mL/m, = 0.03), a higher LA strain S-R (15.8 ± 7.7 vs. 9.0 ± 4.2%, = 0.003), and more pronounced lateral a' wave (5 ± 3 vs. 3 ± 1 m/s, = 0.01), tricuspid a' wave (7 ± 3 vs. 4 ± 2 m/s, = 0.02), average a' wave (6 ± 2 vs. 3 ± 1, = 0.005), and augmentation index corrected for 75 beats per minute (Aix75) (26 ± 13 vs. 37 ± 12, = 0.01). Based on these results, patients were assigned one point for each of the following criteria: RAVi > 36 mL/m, average a' wave > 4, LA strain S-R > 13%. The ROC curve analysis showed that a score of 3 had an AUC for AF recurrence of 0.81 ( < 0.001, CI 0.69-0.91), with a sensitivity of 96% and a specificity of 62%. : LA strain, TDI Doppler, RAVi, and Aix75 measured immediately post-ECV were independent predictors of AF recurrence after ECV.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11818095 | PMC |
http://dx.doi.org/10.3390/jcm14030749 | DOI Listing |
Am J Respir Crit Care Med
March 2025
Imperial College London, National Heart and Lung Institute, London, United Kingdom of Great Britain and Northern Ireland;
JACC Case Rep
January 2025
Division of Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA. Electronic address:
Background: Although rare, embolization of left atrial appendage occlusion (LAAO) devices carries a significant morbidity and mortality burden.
Case Summary: An asymptomatic 77-year-old woman with inability to tolerate anticoagulation due to gastrointestinal bleeding presented for 45-day transesophageal echocardiography following LAAO with a Watchman device, which demonstrated incidental device migration to the left ventricular outflow tract (LVOT). Percutaneous extraction was performed using a novel technique with rat tooth/alligator forceps to successfully retrieve the Watchman from the LVOT using a transaortic approach.
Eur J Haematol
March 2025
Department of Software and Information Systems Engineering, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Background: One of the limiting toxicities of BTKi is the development of atrial fibrillation (AF), with an incidence of 3%-16%.
Aim: This study aimed to identify patients with chronic lymphocytic leukemia (CLL) starting both first- and second-generation BTKis who are at high risk of developing AF using a machine learning approach.
Methods: The CLL cohort is based on data obtained from electronic medical records from Maccabi, the second-largest healthcare organization in Israel.
Europace
March 2025
Cardiology Department, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, OX3 9DU, United Kingdom.
Background And Aims: Advanced technologies such as charge density mapping (CDM) show promise in guiding adjuvant ablation in patients with persistent atrial fibrillation (AF); however, their limited availability restricts widespread adoption. We sought to determine whether regions of the left atrium containing CDM-identified pivoting and rotational propagation patterns during AF could also be reliably identified using more conventional contact mapping techniques.
Methods: Twenty-two patients undergoing de novo ablation of persistent AF underwent both CDM and electroanatomic voltage mapping during AF and sinus rhythm with multiple pacing protocols.
Infez Med
March 2025
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Background: Fever following transcatheter aortic valve implantation (TAVI) poses a clinical challenge, necessitating a comprehensive diagnostic approach to discern between infectious and non-infectious origins. Despite its minimally invasive nature, TAVI disrupts protective anatomical barriers, leading to an increased risk of infection, as well as to aseptic inflammatory responses. Standardized strategies for the management of these patients are lacking.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!